BACKGROUND: To retrospectively compare the accuracies of ultrasound-guided fine-needle aspiration (USFNA) and ultrasound-guided core needle biopsy (USCNB) in the diagnosis of parotid masses. METHODS: A total of 171 patients (aged 17-86 years, mean 54 years) with parotid masses (35 malignant and 136 benign lesions) underwent either USFNA (n = 107) or USCNB (n = 64). The diagnostic accuracies for differentiating benign from malignant lesions of both examinations were compared. Surgical histopathology (n = 104) and clinical diagnosis (n = 67) were used to establish the final diagnoses. RESULTS: USCNB had a significantly higher sensitivity (94.1%) than USFNA (55.6%) (p < 0.05) in differentiating benign lesions from malignant conditions. The specificity and overall accuracy of USCNB were higher than those of USFNA (100% and 98.4% versus 93.3% and 86.9%, respectively). USCNB provided more specific diagnosis than USFNA (100% versus 93.3%, p < 0.05). All six patients with lymphomas who underwent USCNB were accurately diagnosed, whereas all four patients with lymphomas who underwent USFNA were not. CONCLUSIONS: USCNB should be preferred to USFNA when a definite diagnosis of a parotid solid mass is needed.
BACKGROUND: To retrospectively compare the accuracies of ultrasound-guided fine-needle aspiration (USFNA) and ultrasound-guided core needle biopsy (USCNB) in the diagnosis of parotid masses. METHODS: A total of 171 patients (aged 17-86 years, mean 54 years) with parotid masses (35 malignant and 136 benign lesions) underwent either USFNA (n = 107) or USCNB (n = 64). The diagnostic accuracies for differentiating benign from malignant lesions of both examinations were compared. Surgical histopathology (n = 104) and clinical diagnosis (n = 67) were used to establish the final diagnoses. RESULTS: USCNB had a significantly higher sensitivity (94.1%) than USFNA (55.6%) (p < 0.05) in differentiating benign lesions from malignant conditions. The specificity and overall accuracy of USCNB were higher than those of USFNA (100% and 98.4% versus 93.3% and 86.9%, respectively). USCNB provided more specific diagnosis than USFNA (100% versus 93.3%, p < 0.05). All six patients with lymphomas who underwent USCNB were accurately diagnosed, whereas all four patients with lymphomas who underwent USFNA were not. CONCLUSIONS: USCNB should be preferred to USFNA when a definite diagnosis of a parotid solid mass is needed.
Authors: C Carrie Liu; Ashok R Jethwa; Samir S Khariwala; Jonas Johnson; Jennifer J Shin Journal: Otolaryngol Head Neck Surg Date: 2015-10-01 Impact factor: 3.497
Authors: R W Jordan; D P Shlapak; J C Benson; F E Diehn; D K Kim; V T Lehman; G B Liebo; A A Madhavan; J M Morris; P P Morris; J T Verdoorn; C M Carr Journal: AJNR Am J Neuroradiol Date: 2021-12-09 Impact factor: 3.825
Authors: Katharine Julia Hurry; Dilhara Karunaratne; Suzanne Westley; Alessandra Booth; Keith C R B Ramesar; Ting Ting Zhang; Michael Williams; David C Howlett Journal: Br J Radiol Date: 2021-12-03 Impact factor: 3.039
Authors: Andrey A Yarovoy; Evgeniya S Bulgakova; Anna V Shatskikh; Dzhulietta G Uzunyan; Svetlana S Kleyankina; Olesya V Golubeva Journal: Graefes Arch Clin Exp Ophthalmol Date: 2013-03-21 Impact factor: 3.117